Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Armando Santoro Paolo Bidoli Federico Cappuzzo Adolfo Favaretto Francesco Grossi |
| Publication date | April 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |